灵感来自自然的纳米载体,用于改善动脉样硬化的药物治疗
Weihong Ji1,2, Yuanxing Zhang3, Yuanru Deng1,2
1Institute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen, Fujian 361021, PR China.
Regenerative biomaterials
|August 29, 2023
概括
自然启发的纳米载体为动脉样硬化 (AS) 药物输送挑战提供了解决方案. 这些先进的材料利用自然特性进行有针对性的斑块处理和改善治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 心血管研究研究心血管研究
背景情况:
- 动脉样硬化 (AS) 是全球主要的残疾和死亡原因,由动脉斑块和炎症驱动.
- 目前对AS的药物治疗面临着重大交付挑战,限制了治疗疗效.
- 大自然提供了通过生物颗粒和微环境线索提供高效药物输送的模型.
研究的目的:
- 审查以自然为灵感的纳米载体,以改善动脉样硬化中的药物输送.
- 要突出这些纳米载体如何克服当前的治疗障碍.
- 讨论应用这些创新的潜力和挑战.
主要方法:
- 关于用于动脉样硬化的自然灵感纳米载体的文献综述.
- 使用自然成分 (脂质,蛋白质,膜) 的纳米载体设计的分析.
- 检查与自然元素集成的刺激响应合成材料.
主要成果:
- 自然启发的纳米载体显示出长时间循环和动脉硬化斑块的向传递等优势.
- 这些载体促进了特定细胞的向和在疾病部位控制药物释放.
- 它们有效地利用了细胞的自然特性和病态微环境.
结论:
- 自然启发的纳米载体代表了一种有前途的策略,以加强动脉样硬化药物治疗.
- 需要进一步的研究和开发,以应对临床应用中的挑战.
- 这些创新方法对未来的心血管疾病治疗具有重大潜力.
相关概念视频
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Atherosclerosis IV: Nursing Management
21
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
21
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
558
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
558
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
697
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
697
Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Atherosclerosis I: Introduction
10
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
10


